Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

Schulthess J. et al, (2019), Immunity, 50, 432 - 445.e7

Host-microbial crosstalk in the pathogenesis of colon cancer in Primary sclerosing cholangitis

Neyazi M. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S97 - S97

Innate Lymphoid Cells in Intestinal Inflammation

Geremia A. and Arancibia-Cárcamo CV., (2017), Frontiers in Immunology, 8

RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease

de Wit J. et al, (2016), Journal of Allergy and Clinical Immunology, 137, 960 - 963

Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity

Paterson AM. et al, (2015), Journal of Experimental Medicine, 212, 1603 - 1621

SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS

De Wit J. et al, (2014), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 32, 811 - 811

Corrigendum

(2011), International Immunology, 23, 463 - 463

IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease

Geremia A. et al, (2011), Journal of Experimental Medicine, 208, 1127 - 1133

Load More